Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression

Gut

Volumn 58, Issue 1, 2009, Pages 79-89

  Carvalho, B ^a   Postma, C ^a   Mongera, S ^a   Hopmans, E ^a   Diskin, S ^b,c   Van De Wiel, M A ^a,d   Van Criekinge, W ^e   Thas, O ^e   Matthai A ^f   Cuesta, M A ^a   Droste, J S Terhaar Sive ^a   Craanen, M ^a   Schrock E ^f   Ylstra, B ^a   Meijer, G A ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; MESSENGER RNA; TUMOR PROTEIN;

ADENOCARCINOMA; ADENOMA; ADRM1 GENE; ADULT; AGED; AMPLICON; ARTICLE; AURKA GENE; C20ORF20 GENE; C20ORF24 GENE; CANCER GROWTH; CHROMOSOMAL INSTABILITY; CHROMOSOME 20Q; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE; GENE EXPRESSION; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNPC1 GENE; TCFL5 GENE; TH1L GENE; TISSUE MICROARRAY; CHROMOSOME 20; CHROMOSOME ABERRATION; COLORECTAL TUMOR; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADENOMA; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58249089865     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2007.143065     Document Type: Article

References (54)

1. Fearon ER, Vogelstein 8. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
2. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251-70.
3. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386:623-7.
4. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome] and microsatellite instability. J Natl Cancer Inst 2004; 96:261-8.
5. Edelmann L, Edelmann W. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer. Am J Med Genet C Semin Med Genet 2004; 129(1):91-9.
6. di Pietro M, Bellver JS, Menigatti M, et al. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology 2005; 129:1047-59.
7. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002; 123:1109-19.
8. Weiss MM, Kuipers EJ, Postma C, et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 2003; 22:1872-9.
9. Rajagopalan H, Nowak MA, Vogelstein B, et al. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 2003; 3:695-701.
10. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996; 15:234-45.
11. Meijer GA, Hermsen MA, Baak JP, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998; 51:901-9.
12. Douglas EJ, Fiegler H, Rowan A, et al. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 2004; 64:4817-25.
13. Nakao K. Mehta KR, Fridlyand J, et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 2004; 25:1345-57.
14. De Angelis PM, Clausen OP, Schjolberg A, et al. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999; 80:526-35.
15. Nessling M, Solinas-Toldo S, Wilgenbus KK. et al. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998; 23:307-16.
16. Korn WM, Yasutake T, Kuo WL, et al. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 1999; 25:82-90.
17. Kallioniemi A, Kallioniemi OP, Piper J, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994; 91:2156-60.
18. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000; 6:1833-9.
19. Aust DE, Muders M, Kohler A, et al. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis. Scand J Gastroenterol 2004; 39:766-72
20. Wilting SM, Snijders PJ, Meijer GA, et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006; 209:220-30.
21. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003; 200:320-6.
22. Albertson DG, Ylstra B, Segraves R. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000; 25:144-6.
23. Postma C, Hermsen MA, Coffa J, et al. Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 2005; 205:514-21
24. Weiss MM, Hermsen MA, Meijer GA, et al. Comparative genomic hybridisation. Mol Pathol 1999; 52:243-51.
25. Carvalho B, Buffart TE, Reis RM, et al. Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol 2006; 28:283-94.
26. Muris JJ, Ylstra B, Cillessen SA, et al. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas. Br J Haematol 2007; 136:38-47.
27. Qnackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32(Suppl):496-501.
28. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30:207-10
29. Jong K, Marchiori E, Meijer G, et al. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 2004; 20:3636-7.
30. Menten B, Pattyn F, De Prefer K, et al. arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics 2005: 6:124
31. van de Wiel MA, Smeets SJ, Brakenhoff RH, et al. CGHMultiArray: exact P-values for mufti-array comparative genomic hybridization data. Bioinformatics 2005; 21:3193-4.
32. Diskin SJ, Eck T, Greshock J, et al. STAC: a method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Res 2006; 16:1149-58.
33. van Wieringen WN, Belien JA, Vosse SJ. et al. ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data. Bioinformatics 2006; 22:1919-20
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-8
35. Dydensborg AB, Herring E, Auclair J, et al. Normalizing genes for quantitative RT- PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am J Physiol Gastrointest Liver Physiol 2006; 290:G1067-74.
36. Notterman DA, Alon U, Sierk AJ, et al. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001; 61:3124-30.
37. Lin YM, Furukawa Y, Tsunoda T, et al. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 2002; 21:4120-8.
38. Pilarsky C, Wenzig M, Specht T, et al. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 2004; 6:744-50.
39. Shimokawa T, Matsushima S, Tsunoda T, et al. Identification of T0MM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol 2006; 29:381-6.
40. Ptatzer P, Upender MB, Wilson K, et al. Silence of chromosomal amplifications in colon cancer. Cancer Res 2002; 62:1134-8.
41. Tsafrir D, Bacolod M, Selvanayagam Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006: 66:2129-37.
42. Marumoto T, Zhang D, Saya H. Aurora-A-a guardian of poles. Nat Rev Cancer 2005; 5:42-50.
43. Carter SL, Eklund AC, Kohane IS, et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006; 38:1043-8.
44. Hidaka S, Yasutake T, Takeshita H, et al. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000; 6:2712-7.
45. Rooney PH, Boonsong A, McFadyen MC, et al. The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol 2004; 204:282-8.
46. Brinkmann U, Gallo M. Polymeropoulos MH, et al. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res 1996; 6:187-94.
47. Siep M, Sleddens-Linkels E, Mulders S, et al. Basic helix-loop-helix transcription factor Tcfl5 interacts with the Calmegin gene promoter in mouse spermatogenesis. Nucleic Acids Res 2004; 32:6425-36.
48. Cai Y, Jin J, Tomomori-Sato C, et al. Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex. J Biol Chem 2003; 278:42733-6.
49. Liu W, Shen X, Yang Y, et al. Trihydrophobin 1 is a new negative regulator of A-Raf kinase. J Biol Chem 2004; 279:10167-75.
50. Jorgensen JP, Lauridsen AM, Kristensen P, et al. Adrm1, a putative cell adhesion regulating protein, is a novel proteasome-associated factor. J Mol Biol 2006; 360:1043-52.
51. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17:3052-65.
52. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20:189-93.
53. Hata T, Furukawa T, Sunamura M, et al. RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65:2899-905.
54. Dardousis K, Voolstra C, Roengvoraphoj M, et al. Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells. Mol Ther 2007; 15:94-102.